Tenet Healthcare (THC) reported solid Q2 results but its shares fell amid policy uncertainty around the Affordable Care Act exchanges, RBC Capital Markets said in a note Tuesday.
RBC analysts Ben Hendrix and Michael Murray said Q2 earnings call raised "widespread concern" over the operating backdrop for 2026 around the ACA exchanges, which is impairing visibility for hospital and payors alike into next year.
"We are not surprised to see management withhold preliminary views on 2026," the analysts said.
"Even so, THC remains our top hospital pick on strong
fundamentals, which we believe are not adequately reflected in the current multiple," they added.
RBC kept its $189 price target and outperform rating.
Price: 158.01, Change: +2.04, Percent Change: +1.31
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.